-
EP1501499
European procedure
Extract from the Register of European Patents
EP About this file: EP1501499
| EP1501499 - TRANS-EPICUTANEOUS ADMINISTRATION FORM FOR TREATING RESTLESS LEG SYNDROME [Right-click to bookmark this link] | Status | Patent revoked Status updated on 20.03.2015 Database last updated on 29.03.2025 | Most recent event Tooltip | 29.07.2016 | Lapse of the patent in a contracting state | published on 31.08.2016 [2016/35] | 29.07.2016 | Change - lapse in a contracting state | published on 31.08.2016 [2016/35] | Applicant(s) | For all designated states UCB Pharma GmbH Alfred-Nobel-Strasse 10 40789 Monheim / DE | [2010/36] |
| Former [2008/10] | For all designated states SCHWARZ PHARMA AG Alfred-Nobel-Strasse 10 40789 Monheim/Rhld. / DE | ||
| Former [2005/05] | For all designated states SCHWARZ PHARMA AG Alfred-Nobel-Strasse 10 D-40789 Monheim/Rhld. / DE | Inventor(s) | 01 /
LAUTERBACH, Thomas Am Rittersberg 44 40595 Düsseldorf / DE | 02 /
SCHOLLMAYER, Erwin Humperdinckstrasse 6 51375 Leverkusen / DE | [2005/05] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
| Former [2008/31] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | ||
| Former [2005/05] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | Application number, filing date | 03727432.1 | 05.05.2003 | [2005/05] | WO2003EP04685 | Priority number, date | DE20021020230 | 06.05.2002 Original published format: DE 10220230 | [2005/05] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO03092677 | Date: | 13.11.2003 | Language: | DE | [2003/46] | Type: | A1 Application with search report | No.: | EP1501499 | Date: | 02.02.2005 | Language: | DE | The application published by WIPO in one of the EPO official languages on 13.11.2003 takes the place of the publication of the European patent application. | [2005/05] | Type: | B1 Patent specification | No.: | EP1501499 | Date: | 05.03.2008 | Language: | DE | [2008/10] | Search report(s) | International search report - published on: | EP | 13.11.2003 | Classification | IPC: | A61K31/381, A61K31/045 | [2005/05] | CPC: |
A61K9/7061 (EP);
A61K31/381 (EP,KR);
A61K9/70 (KR);
A61K9/7069 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/08 (EP);
A61P25/14 (EP);
A61P43/00 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/05] | Extension states | AL | 19.10.2004 | LT | 19.10.2004 | LV | 19.10.2004 | MK | 19.10.2004 | Title | German: | TRANSEPIKUTANE DARREICHUNGSFORM ZUR BEHANDLUNG DES RESTLESS LEG SYNDROMS | [2005/05] | English: | TRANS-EPICUTANEOUS ADMINISTRATION FORM FOR TREATING RESTLESS LEG SYNDROME | [2005/05] | French: | FORME GALENIQUE TRANSCUTANEE POUR LE TRAITEMENT DU SYNDROME DES JAMBES SANS REPOS | [2005/05] | Entry into regional phase | 19.10.2004 | National basic fee paid | 19.10.2004 | Designation fee(s) paid | 19.10.2004 | Examination fee paid | Examination procedure | 11.09.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 19.10.2004 | Amendment by applicant (claims and/or description) | 19.10.2004 | Examination requested [2005/05] | 11.04.2005 | Despatch of a communication from the examining division (Time limit: M06) | 20.10.2005 | Reply to a communication from the examining division | 21.11.2005 | Despatch of a communication from the examining division (Time limit: M04) | 15.03.2006 | Reply to a communication from the examining division | 02.10.2007 | Communication of intention to grant the patent | 15.01.2008 | Fee for grant paid | 15.01.2008 | Fee for publishing/printing paid | Opposition(s) | Opponent(s) | 01
03.12.2008
ADMISSIBLE Hexal AG Industriestrasse 25 83607 Holzkirchen / DE Opponent's representative von Seebach, Malte, et al, et al Maiwald Patentanwalts GmbH Jungfernstieg 38 20354 Hamburg / DE | [N/P] |
| Former [2009/02] | |||
| Opponent(s) | 01
03.12.2008
ADMISSIBLE Hexal AG Industriestrasse 25 83607 Holzkirchen / DE Opponent's representative von Seebach, Malte, et al, et al Maiwald Patentanwalts GmbH Jungfernstieg 38 D-20354 Hamburg / DE | 15.01.2009 | Invitation to proprietor to file observations on the notice of opposition | 13.05.2009 | Reply of patent proprietor to notice(s) of opposition | 16.09.2010 | Date of oral proceedings | 21.10.2010 | Despatch of interlocutory decision in opposition | 21.10.2010 | Despatch of minutes of oral proceedings | 27.08.2014 | Legal effect of revocation of patent [ N /P ] | 27.08.2014 | Legal effect of revocation of patent [2015/17] | 30.01.2015 | Despatch of communication that the patent will be revoked | Appeal following opposition | 13.12.2010 | Appeal received No. T2436/10 | 23.02.2011 | Statement of grounds filed | 27.08.2014 | Result of appeal procedure: revocation of the patent | 27.12.2010 | Appeal received No. T2436/10 | 22.02.2011 | Statement of grounds filed | 27.08.2014 | Result of appeal procedure: revocation of the patent | 27.08.2014 | Date of oral proceedings | 10.09.2014 | Minutes of the oral proceedings despatched | Fees paid | Renewal fee | 12.05.2005 | Renewal fee patent year 03 | 23.03.2006 | Renewal fee patent year 04 | 14.05.2007 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CH | 05.03.2008 | CY | 05.03.2008 | LI | 05.03.2008 | [2016/35] |
| Former [2015/20] | CH | 05.03.2008 | |
| CY | 05.03.2008 | ||
| LI | 05.03.2008 | ||
| Former [2009/43] | CY | 05.03.2008 | Cited in | International search | [Y] - FREEMAN ALAN ET AL, "Ropinirole for restless legs syndrome (RLS): An Open-Label and Double-Blind Placebo-Controlled Study.", NEUROLOGY, 53rd Annual Meeting of the American Academy of Neurology;Philadelphia, PA, USA; May 05-11, 2001, (20010424), vol. 56, no. 8 Supplement 3, ISSN 0028-3878, page A5, XP008020183 [Y] 1-18 * Background, Conclusions * | [Y] - ZUCCONI M ET AL, "Effectiveness of the D2-agonist cabergoline as single-drug therapy for Restless Legs Syndrome: Clinical and actigraphic evaluation.", SLEEP (ROCHESTER), 15th Annual Meeting of the Associated Professional Sleep Societies;Chicago, Illinois, USA; June 05-10, 2001, (20010415), vol. 24, no. Abstract Supplement, ISSN 0161-8105, page A19, XP008020184 [Y] 1-18 * Introduction, Conclusions * | [Y] - HUNDEMER H ET AL, "The safety of pergolide in the treatment of restless legs syndrome RLS: Results of a randomized long-term multicenter trial of pergolide in the treatment of RLS.", SLEEP (ROCHESTER), 15th Annual Meeting of the Associated Professional Sleep Societies;Chicago, Illinois, USA; June 05-10, 2001, (20010415), vol. 24, no. Abstract Supplement, ISSN 0161-8105, page A17, XP008020186 [Y] 1-18 * Introduction, Conclusions * | [Y] - SILBER M H ET AL, "Pramipexole in the management of restless legs syndrome: An extended study.", SLEEP (ROCHESTER), 15th Annual Meeting of the Associated Professional Sleep Societies;Chicago, Illinois, USA; June 05-10, 2001, (20010415), vol. 24, no. Abstract Supplement, ISSN 0161-8105, page A18, XP008020185 [Y] 1-18 * Introduction, Results * | [Y] - METMAN LEO VERHAGEN ET AL, "Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease.", CLINICAL NEUROPHARMACOLOGY, (200105), vol. 24, no. 3, ISSN 0362-5664, pages 163 - 169, XP008020182 [Y] 1-18 * page 164, column L, paragraph 2 * | Examination | DE10041479 | by applicant | - A. FREEMNAN ET AL., NEUROLOGY, (2001), vol. 56, no. 8, page A5 | - M. ZUCCONI ET AL., SLEEP, (2001), vol. 24, page A19 | - H. HUNDERMER ET AL., SLEEP, (2001), vol. 24, page A17 | - M. SILBER ET AL., SLEEP, (2001), vol. 24, page A18 | - L.V. METMAN ET AL., CLINICAL NEUROPHARMACOLOGY, (2001), vol. 24, no. 3, pages 163 - 169 |